Gastroenterology - Lebanon | Statista Market Forecast

The Gastroenterology market in Lebanon is expected to witness a significant increase in revenue, reaching an estimated value of US$90.21m by 2024.
This projection indicates a promising future for the Gastroenterology market sector in the country.
Furthermore, it is anticipated that the revenue in the Gastroenterology market will continue to grow at an impressive annual rate of -2.67% from 2024 to 2029.
This substantial growth is expected to result in a market volume of approximately US$78.81m by the end of 2029.
These figures highlight the potential for substantial expansion and development within the Gastroenterology market industry in Lebanon.
When considering the global landscape, it is worth noting that United States is projected to generate the highest revenue in the Gastroenterology market.
In 2024 alone, United States is expected to contribute US$60.48bn to the overall revenue.
This showcases the dominance of the United States in this particular market, both domestically and on a global scale.
Lebanon's gastroenterology market is witnessing an increasing demand for advanced endoscopic procedures due to a growing prevalence of gastrointestinal diseases.

Definition:
Gastroenterology refers to medical treatments and procedures that are provided to patients who require overnight hospitalization for digestive system disorders, e.g., gastrointestinal motility disorders, inflammatory bowel diseases, and liver diseases. Patients are provided with a variety of services during their stay in the hospital. These include endoscopic procedures (e.g., colonoscopies or upper endoscopies), surgical interventions, and changes to their diet and lifestyle that help manage the underlying condition and improve digestive health.

Additional information:
The Gastroenterology market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Diagnostic and therapeutic endoscopic procedures
Surgical interventions for digestive system diseases
Monitoring and management of patients receiving nutrition support

Treatment of chronic digestive system diseases that do not require hospitalization
Routine follow-up care after hospitals discharge

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Inflammatory bowel disease (IBD) refers to disorders that cause chronic inflammation of the digestive tract. The two most common types of IBD are Crohn’s disease and ulcerative colitis. IBD can be difficult to diagnose because symptoms are typical of other illnesses and diseases and can vary from person to person. Symptoms of IBD include diarrhea, stomach pain and cramping, bleeding ulcers, weight loss, and fatigue. A survey of patients with Crohn's disease in North America and Europe found that 56 percent had experienced tiredness/exhaustion/fatigue in the past month, while 53 percent had abdominal pain/cramps. Such symptoms were only slightly less common among patients with ulcerative colitis.